Randomised controlled trial of brief intervention with biofeedback and hypnotherapy in patients with refractory irritable bowel syndrome

Journal of the Royal College of Physicians of Edinburgh

Volumn 43, Issue 1, 2013, Pages 15-23

  Dobbin, A ^a   Dobbin, J ^b   Ross, S C ^b   Graham, C ^c   Ford, M J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Foundation for Positive Mental Health   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Biofeedback; Hypnotherapy; Irritable bowel syndrome

Indexed keywords

ADULT; ANXIETY; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEPRESSION; DISEASE RESISTANCE; DISEASE SEVERITY; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; HUMAN; HYPNOSIS; IRRITABLE COLON; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

BIOFEEDBACK; HYPNOTHERAPY; IRRITABLE BOWEL SYNDROME;

ADULT; ANXIETY; BIOFEEDBACK, PSYCHOLOGY; DEPRESSION; FEMALE; HUMANS; HYPNOSIS; IRRITABLE BOWEL SYNDROME; QUESTIONNAIRES;

EID: 84875727506     PISSN: 14782715     EISSN: None     Source Type: Journal    
DOI: 10.4997/JRCPE.2013.104     Document Type: Article

References (64)

1. Longstreth GF, Thompson WG, Chey WD et al. Functional bowel disorders. Gastroenterology 2006; 130:1480-91. http://dx.doi.org/10.1053/j.gastro.2005.11.061
2. Rome 111: The functional gastrointestinal disorders. 3rd ed. Lawrence, Kansas: Allen Press; 2006.
3. Ferguson A, Sircus W, Eastwood MA. Frequency of 'functional' gastrointestinal disorders. Lancet 1977; 2:613-4. http://dx.doi.org/10.1016/S0140-6736(77)91466-0
4. Harvey RF, Salih SY, Read AE. Organic and functional disorders in 2000 gastroenterology outpatients. Lancet 1983; 1: 632-4. http://dx.doi.org/10.1016/S0140-6736(83)91802-0
5. Halder SL, Locke GR, Talley NJ et al. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther 2004; 19:233-42. http://dx.doi.org/10.1111/j.0269-2813.2004.01807.x
6. Spiegel BM, Gralnek IM, Bolus R et al. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch Intern Med 2004; 164:1773-80. http://dx.doi.org/10.1001/archinte.164.16.1773
7. Whorwell PJ, McCallum M, Creed FH et al. Non-colonic features of irritable bowel syndrome. Gut 1986; 27:37-40. http://dx.doi.org/10.1136/gut.27.1.37
8. Nyhlin H, Ford MJ, Eastwood J et al. Non-alimentary aspects of the irritable bowel syndrome. J Psychosom Res 1993; 37:155-62. http://dx.doi.org/10.1016/0022-3999(93)90082-Q
9. Drossman D, Li Z, Andruzzi E et al. US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38:1569-80. http://dx.doi.org/10.1007/BF01303162
10. Talley NJ, Gabriel SE, Harmsen WS et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995; 109:1736-41. http://dx.doi.org/10.1016/0016-5085(95)90738-6
11. Drossman DA, Creed FH, Olden KW et al. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999; 45:II25-30. http://dx.doi.org/10.1136/gut.45.2008.ii25
12. Ford MJ, Miller PM, Eastwood J et al. Life events, psychiatric illness and the irritable bowel syndrome. Gut 1987; 28:160-5. http://dx.doi.org/10.1136/gut.28.2.160
13. Roelofs K, Spinhoven P. Trauma and medically unexplained symptoms towards an integration of cognitive and neuro-biological accounts. Clin Psychol Rev 2007;27:798-820. http://dx.doi.org/10.1016/j.cpr.2007.07.004
14. Myers B, Greenwood-Van Meerveld B. Role of anxiety in the pathophysiology of irritable bowel syndrome: importance of the amygdala. Front Neurosci 2009; 3:47. http://dx.doi.org/10.3389/neuro.21.002.2009
15. Ford MJ, Camilleri M, Zinsmeister AR et al. Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology 1995; 109:1772-80. http://dx.doi.org/10.1016/0016-5085(95)90743-2
16. Phillips ML, Gregory LJ, Cullen S et al. The effect of negative emotional context on neural and behavioural responses to oesophageal stimulation. Brain 2003; 126: 669-84. http://dx.doi.org/10.1093/brain/awg065
17. Wilder-Smith C, Schindler D, Lovblad K et al. Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut 2004; 53:1595-1601. http://dx.doi.org/10.1136/gut.2003.028514
18. Myers B, Greenwood-Van Meerveld B. Corticosteroid receptormediated mechanisms in the amygdala regulate anxiety and colonic sensitivity. Am J Physiol Gastrointest Liver Physiol 2007; 292:G1622-9. http://dx.doi.org/10.1152/ajpgi.00080.2007
19. Myers DA, Gibson M, Schulkin J et al. Corticosterone implants to the amygdala and type 1 CRH receptor regulation: effects on behavior and colonic sensitivity. Behav Brain Res 2005; 161:39-44. http://dx.doi.org/10.1016/j.bbr.2005.03.001
20. Shepard JD, Myers DA. Strain differences in anxiety-like behavior: association with corticotropin-releasing factor. Behav Brain Res 2008; 186:239-45. http://dx.doi.org/10.1016/j.bbr.2007.08.013
21. Naliboff BD, Berman S, Chang L et al. Sex-related differences in IBS patients: central processing of visceral stimuli. Gastroenterology 2003;124:1738-47. http://dx.doi.org/10.1016/S0016-5085(03)00400-1
22. Weiser MJ, Handa RJ. Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuroscience 2009; 159:883-95. http://dx.doi.org/10.1016/j.neuroscience.2008.12.058
23. Waring WS, Chui M, Japp A et al. Autonomic cardiovascular responses are impaired in women with irritable bowel syndrome. J Clin Gastroenterol 2004; 38:658-63. http://dx.doi.org/10.1097/01.mcg.0000135362.35665.49
24. Tillisch K, Mayer EA, Labus JS et al. Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut 2005; 54:1396-401. http://dx.doi.org/10.1136/gut.2004.058685
25. Buysschaert M, Donckier J, Dive A et al. Gastric acid and pancreatic polypeptide responses to sham feeding are impaired in diabetic subjects with autonomic neuropathy. Diabetes 1985; 34:1181-7. http://dx.doi.org/10.2337/diabetes.34.11.1181
26. Emmanuel AV, Kamm MA. Laser doppler flowmetry as a measure of extrinsic colonic innervation in functional bowel disease. Gut 2000; 46:212-7. http://dx.doi.org/10.1136/gut.46.2.212
27. Talley NJ. Pharmacologic therapy for the irritable bowel syndrome. Am J Gastroenterol 2003; 98: 750-8. http://dx.doi.org/10.1111/j.1572-0241.2003.07306.x
28. Hypnotherapy for functional gastrointestinal disorders. Drug Ther Bull 2005; 43:45-8. http://dx.doi.org/10.1136/dtb.2005.43645
29. Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome the effect of hypnotherapy. Aliment Pharmacol Ther 1996; 10:91-5. http://dx.doi.org/10.1111/j.1365-2036.1996.tb00181.x
30. Rainville P, Hofbauer R, Bushnell M et al. Hypnosis modulates activity in brain structures involved in the regulation of consciousness. J Cogn Neurosci 2002; 14:887-901. http://dx.doi.org/10.1162/089892902760191117
31. Williamson JW, McColl R, Mathews D et al. Brain activation by central command during actual and imagined handgrip under hypnosis. J Appl Physiol 2002; 92:1317-24.
32. Beaugerie L, Burger AJ, Cadranel JF et al. Modulation of orocaecal transit time by hypnosis. Gut 1991; 32:393-4. http://dx.doi.org/10.1136/gut.32.4.393
33. Whorwell PJ, Houghton LA, Taylor EE et al. Physiological effects of emotion: assessment via hypnosis. Lancet 1992; 340:69-72. http://dx.doi.org/10.1016/0140-6736(92)90394-I
34. Prior A, Whorwell PJ. Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut 1990; 31:896-8. http://dx.doi.org/10.1136/gut.31.8.896
35. Houghton LA, Calvert EL, Jackson NA et al. Visceral sensation and emotion: a study using hypnosis. Gut 2002; 51:701-4. http://dx.doi.org/10.1136/gut.51.5.701
36. Lea R, Houghton LA, Calvert EL et al. Gut-focused hypnotherapy normalises disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003; 17:635-42. http://dx.doi.org/10.1046/j.1365-2036.2003.01486.x
37. DeBenedittis G, Cigada M, Bianchi A et al. Autonomic changes during hypnosis: a heart rate variability power spectrum analysis as a marker of sympatho-vagal balance. Int J Clin Exp Hypn 1994; 42:140-52. http://dx.doi.org/10.1080/00207149408409347
38. Kellow JE, Langeluddecke PM, Eckersley GM et al. Progressive muscular relaxation and motility of the small intestine: studies in normal subjects and patients with irritable bowel syndrome. Neurogastroenterol Motil 1992; 4:47. http://dx.doi.org/10.1111/j.1365-2982.1992.tb00078.x
39. Bassotti G, Whitehead WE. Biofeedback as a treatment approach to gastrointestinal tract disorders. Amer J Gastroenterol 1994; 89:158-64.
40. Bassotti G, Whitehead WE. Biofeedback, relaxation training and cognitive behaviour modification as treatments for lower functional gastrointestinal disorders. QJM 1997; 90:545-50. http://dx.doi.org/10.1093/qjmed/90.8.545
41. Blanchard EB. Irritable bowel syndrome: psychosocial assessment and treatment. Washington, DC: American Psychological Association; 2001. http://dx.doi.org/10.1037/10393-000
42. DeGuire S, Gevirtz R, Hawkinson D et al. Breathing retraining: a three-year follow-up study of treatment for hyperventilation syndrome and associated functional cardiac symptoms. Biofeedback Self Regul 1996; 21:191-8. http://dx.doi.org/10.1007/BF02284695
43. Gevirtz R. Resonant frequency training to restore autonomic homeostasis for treatment of psychophysiological disorders. Biofeedback 1999; 27:7-9.
44. Wilhelm FH, Gevirtz R, Roth WT. Respiratory dysregulation in anxiety, functional cardiac and pain disorders: assessment, phenomenology, and treatment. Behav Modif 2001; 25:513-45. http://dx.doi.org/10.1177/0145445501254003
45. Del Poso J, Gevirtz R. The effect of resonant frequency cardiac biofeedback training on heart rate variability in a cardiac rehabilitation population. Appl Psychophysiol Biofeedback 2002; 27:311-3
46. Ryan M, Gevirtz R. Biofeedback-based psychophysiological treatment in a primary care setting: an initial feasibility study. Appl Psychophysiol Biofeedback 2004; 29:79-93. http://dx.doi.org/10.1023/B:APBI.0000026635.03016.ef
47. Hjelland IE, Svebak S, Berstad A et al. Breathing exercises with vagal biofeedback may benefit patients with functional dyspepsia. Scand J Gastroenterol 2007; 42:1054-62. http://dx.doi.org/10.1080/00365520701259208
48. Sowder E, Gevirtz R, Shapiro W et al. Restoration of vagal tone: a possible mechanism for functional abdominal pain. Appl Psychophysiol Biofeedback 2010; 35:199-206. http://dx.doi.org/10.1007/s10484-010-9128-8
49. Lehrer PM, Vaschillo E, Vaschillo B. Resonant frequency biofeedback training to increase cardiac variability: rationale and manual for training. Appl Psychophysiol Biofeedback 2000; 25:177-91. http://dx.doi.org/10.1023/A:1009554825745
50. Talley NJ, Owen BK, Boyce P et al. Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol 1996; 91:277-83.
51. Irvine EJ, Whitehead WE, Chey WD et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006; 1306:1538-51. http://dx.doi.org/10.1053/j.gastro.2005.11.058
52. Gholamrezaei A, Ardestani SK, Emami MH. Where does hypnotherapy stand in the management of irritable bowel syndrome? A systematic review. J Altern Complement Med 2006; 12:517-27. http://dx.doi.org/10.1089/acm.2006.12.517
53. Song HS, Lehrer PM. The effects of specific respiratory rates on heart rate and heart rate variability. Appl Psychophysiol Biofeedback 2003; 28:13-23. http://dx.doi.org/10.1023/A:1022312815649
54. Waxman D, editor. Hartland's medical and dental hypnosis. 3rd ed. London: Balliere Tindall; 1989.
55. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997;11: 395-402. http://dx.doi.org/10.1046/j.1365-2036.1997.142318000.x
56. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67:361-70. http://dx.doi. org/10.1111/j.1600-0447.1983.tb09716.x
57. Zijdenbos IL, de Wit NJ, van der Heijden GJ et al. Psychological treatments for the management of irritable bowel syndrome [Internet]. Cochrane Summaries; 2009 [cited 2012 Dec 21]. Available from: http://summaries.cochrane.org/CD006442/psychological-treatments-for-the-management-of-irritable-bowel-syndrome
58. Patel SM, Stason WB, Legedza A et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil 2005; 17:332-40. http://dx.doi.org/10.1111/j.1365-2982.2005.00650.x
59. Kaptchuk TJ, Kelley JM, Conboy LA et al. Components of the placebo effect: a randomized controlled trial in irritable bowel syndrome. BMJ 2008; 336:999-1003. http://dx.doi.org/10.1136/bmj.39524.439618.25
60. Enck P, Horing B, Weimer K et al. Placebo responses and placebo effects in functional bowel disorders. Eur J Gastroenterol Hepatol 2012; 24:1-8. http://dx.doi.org/10.1097/MEG.0b013e32834bb951
61. Gruzelier JH, Brow TD. Psychophysiological evidence for a state theory of hypnosis and susceptibility. J Psychosom Res 1985; 29: 287-302. http://dx.doi.org/10.1016/0022-3999(85)90056-X
62. Ljótsson B, Andersson G, Andersson E et al. Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterol 2011; 11:110. http://dx.doi.org/10.1186/1471-230X-11-110
63. Elkin I, Shea MT, Watkins JT et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry 1989; 46:971-82. http://dx.doi.org/10.1001/archpsyc.1989.01810110013002
64. Blatt S, Zuroff D, Quinlan D et al. Interpersonal factors in brief treatment of depression: further analysis of the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol 1996; 64:162-71. http://dx.doi.org/10.1037/0022-006X.64.1.162